Invention Grant
- Patent Title: Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
-
Application No.: US15703828Application Date: 2017-09-13
-
Publication No.: US10765686B2Publication Date: 2020-09-08
- Inventor: Ulhas R. Dhuppad , Ashok Katkurwar , Yashwant Gupta , Rajesh Ankam , Chandrakant Dhatrak
- Applicant: GLENMARK SPECIALTY S.A.
- Applicant Address: CH La Chaux-de-Fonds
- Assignee: GLENMARK SPECIALTY S.A.
- Current Assignee: GLENMARK SPECIALTY S.A.
- Current Assignee Address: CH La Chaux-de-Fonds
- Agency: Blank Rome LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@62f49429
- Main IPC: A61K31/58
- IPC: A61K31/58 ; A61K9/00 ; A61K9/10 ; A61K31/335 ; A61K47/36 ; A61K47/38
Abstract:
The present invention relates to a stable fixed dose aqueous pharmaceutical composition (e.g., contained in a container) for nasal administration to a human, comprising mometasone or its salt, olopatadine or its salt. The composition may further include a hydrocolloid. The invention also relates to a process for preparing the pharmaceutical composition, and the use of the pharmaceutical composition in the treatment of rhinitis in a subject.
Public/Granted literature
- US20180000844A1 STABLE FIXED DOSE PHARMACEUTICAL COMPOSITION COMPRISING MOMETASONE AND OLOPATADINE Public/Granted day:2018-01-04
Information query
